43
Ventilatory support in special situations Dr.Balamugesh.T, MD, DM Dept. of Pulmonary Medicine, CMC, Vellore.

Ventilatory support in special situations balamugesh

Embed Size (px)

Citation preview

Page 1: Ventilatory support in special situations   balamugesh

Ventilatory supportin special situations

Dr.Balamugesh.T, MD, DM

Dept. of Pulmonary Medicine,

CMC, Vellore.

Page 2: Ventilatory support in special situations   balamugesh

And the Lord God formed man of the dust of the ground, and breathed into his nostrils and

breath of life, and man become a living soul.

Genesis 2:7

Page 3: Ventilatory support in special situations   balamugesh

• ARDS• COPD• Bronchial asthma• Bronchopleural fistula

Page 4: Ventilatory support in special situations   balamugesh

ARDS

• Acute onset• Hypoxia- PaO2/FiO2<200• Bilateral infiltrates on CXR• Absence of left atrial hypertension

Mortality - 26% to 74%

Page 5: Ventilatory support in special situations   balamugesh

Ventilation Induced Lung Injury

• Volutrauma – over distention of alveoli• Barotrauma – high inflation pressures• Atelectrauma - repetitive opening and

closing of alveoli• Biotrauma - up-regulated cytokine

release• Oxygen toxicity

Page 6: Ventilatory support in special situations   balamugesh

Ventilation in ARDS

• Which mode?• How much FiO2?• How much PEEP?• How much VT?• Target?• What if refractory ARDS?

Page 7: Ventilatory support in special situations   balamugesh

Which mode?

• Volume assist/control commonly used• Plateau-pressure goal ≤30 cm of water

ARDS Clinical Trials Network

Page 8: Ventilatory support in special situations   balamugesh

How much FiO2?

• Least FiO2 to achieve Oxygenation goal• PaO2 55–80 mm Hg• SpO2 88–95%

• FiO2 > 60% risk of oxygen toxicity.

Page 9: Ventilatory support in special situations   balamugesh

How much Tidal volume? ARDS

Network

• Low tidal volume -31%

(6 mL/kg predicted body weight)• Conventional tidal volume -

40%

(12 mL/kg)

Mortality

Page 10: Ventilatory support in special situations   balamugesh

PEEP

• Improves oxygenation by providing movement of fluid from the alveolar to the interstitial space,

• Prevent cyclical alveolar collapse• Recruitment of small airways collapsed

alveoli, • Increase in FRC

Page 11: Ventilatory support in special situations   balamugesh

Open Lung Ventilation (OLV)

• Objective - maintenance of adequate oxygenation and avoidance of cyclic opening and closing of alveolar units by selecting a level of PEEP that allows the majority of units to remain inflated during tidal ventilation

• Trade off - Hypercapnia

Page 12: Ventilatory support in special situations   balamugesh

PEEP….

• The lower inflection point on the static pressure–volume curve represents alveolar opening (or “recruitment”).

• “optimal PEEP” - The pressure just above this point, is best for alveolar recruitment

• usually 10 to 18 mmHg

Page 13: Ventilatory support in special situations   balamugesh

optimal PEEP

J J Cordingley, Thorax 2002;57

Page 14: Ventilatory support in special situations   balamugesh

How much PEEP?

• Low PEEP(8.3±3.2 cm of water)• High PEEP (13.2±3.5 cm)

No difference in outcomes if VT- 6ml/kg and Plat. Pressure <30cm

N Engl J Med 2004;351

Page 15: Ventilatory support in special situations   balamugesh

Permissive hypercapia –

• usually well tolerated• Consequences

• myocardial depression,• Pulmonary hypertension• Raised ICT

• Increase RR• Judicious bicarbonate• Tracheal gas insufflation – to wash out dead

space CO2

Page 16: Ventilatory support in special situations   balamugesh

Protective lung ventilation protocol from the ARDSNet study

• Initial tidal volume – 6ml/kg• Plat. Pressure <30cm H20• Oxygenation goal PaO2 = 55 - 80 mmHg or

pulse oximetry oxygen saturation 88–95%• I:E ratio 1:1–1:3• Goal arterial pH = 7.30–7.40 

• If pH < 7.30, increase respiratory rate up to 35 breaths/min 

• If pH < 7.30 and respiratory rate = 35, consider starting intravenous bicarbonate

Page 17: Ventilatory support in special situations   balamugesh

Refractory hypoxia

• 1. Neuromuscular blocking agents (if not already in use)

• 2. Prone position ventilation• 3. Recruitment maneuvers• 4. Inverse ratio ventilation, • 5. Miscellaneous –

• nitric oxide, • high-frequency ventilation, • extracorporeal membrane oxygenation, or • partial liquid ventilation

Page 18: Ventilatory support in special situations   balamugesh

Prone position ventilation

• Improve oxygenation• Better FRC• Recruitment of dorsal lung• Better clearance of secretion• Better ventilation-perfusion matching

• Potential problems• facial oedema, eye damage• dislodgment of endotracheal tubes and

intravascular catheters• Difficulty in resuscitation

No differences in clinical outcome

Page 19: Ventilatory support in special situations   balamugesh

Recruitment manoeuvres

• Sigh function in ventilators• By ambu bag• Sustained inflation or CPAP of 30-45

cm H20 for 20-120 sec.

Page 20: Ventilatory support in special situations   balamugesh

Inverse ratio ventilation

• Prolongation of the inspiratory time as a method of recruitment

• Pressure control ventilation to increase the I:E ratio to 1:1 or 2:1

• hyperinflation and the generation of intrinsic PEEP

Page 21: Ventilatory support in special situations   balamugesh

Obstructive lung disease

• COPD• Asthma

Page 22: Ventilatory support in special situations   balamugesh

Indications for NIV for AE-COPD

GOLD 2005

Page 23: Ventilatory support in special situations   balamugesh

Exclusion criteria

GOLD 2005

Page 24: Ventilatory support in special situations   balamugesh

Indications forInvasive Mechanical Ventilation

GOLD 2005

Page 25: Ventilatory support in special situations   balamugesh

Think twice

• Reversibility of the precipitating event,• Patient’s/relative’s wishes, and • Availability of intensive care facilities• Failure to wean

Mortality among COPD patients with respiratory failure is no greater than mortality among patients ventilated for non-COPD causes

GOLD 2005

Page 26: Ventilatory support in special situations   balamugesh

Post-Intubation hypotension

• Reduced venous return secondary to positive intrathoracic pressure due to bagging

• Direct vasodilation and reduced sympathetic tone induced by sedative agents

Page 27: Ventilatory support in special situations   balamugesh

Mechanical ventilation

• Avoid overcorrection of respiratory acidosis and life threatening alkalosis.

• Prolonged expiratory time. I:E – 1:2.5 to 1:3.

• Low Respiratory Rate- 10-14/mt.• Limited tidal volume

Page 28: Ventilatory support in special situations   balamugesh

PEEP

• PEEPe beneficial• Reduce gas trapping by stenting open the

airways• Reduce the work to trigger inspiratory flow

• As PEEPe is applied, tidal volume will increase without an increase in airway pressure until PEEPe exceeds PEEPi

Page 29: Ventilatory support in special situations   balamugesh

Post extubation NIV

• Allow early extubation• Prevent post extubation respiratory

failure

Page 30: Ventilatory support in special situations   balamugesh

Asthma

Page 31: Ventilatory support in special situations   balamugesh

NIV in asthma

• Few trials• Trial of NIV over 1–2 hours in an ICU if

there are no contraindications

Page 32: Ventilatory support in special situations   balamugesh

NIV in acute bronchial asthma

• FEV1<40%, PaCO2 <40mm Hg• Conventional medical management Vs

BiPAP 15/5 for 3 hours

Chest. 2003;123

Page 33: Ventilatory support in special situations   balamugesh

NIV in asthma….

80% NIV group increased FEV1 by >50% as compared to baseline, vs 20% of control patients (p < 0.004)

alleviate the attack faster, and significantly reduce the need for

hospitalization.

Page 34: Ventilatory support in special situations   balamugesh

Endotracheal intubation

• Absolute indications• Cardiopulmonary arrest and • Deteriorating consciousness

• Relative• Progressive deterioration, hypercapnia with

increasing distress or physical exhaustion

Page 35: Ventilatory support in special situations   balamugesh

• Intubation performed/supervised by experienced anaesthetists or intensivists

• Use larger endotracheal tube

Page 36: Ventilatory support in special situations   balamugesh

• FiO2 = 1.0 (initially)• Long expiratory time (I:E ratio >1:2)• Low tidal volume 5–7 ml/kg• Low ventilator rate (8–10 breaths/min)• Set inspiratory pressure 30–35 cm H2O on pressure control ventilation or limit peak inspiratory pressure to <40 cm H2O• Minimal PEEP <5 cm H2O

Page 37: Ventilatory support in special situations   balamugesh

Aerosol delivery

Metered dose inhaler (MDI) system• Spacer or holding chamber

• Location in inspiratory limb rather than Y piece

• No humidification (briefly discontinue)

• Actuate during lung inflation

• Large endotracheal tube internal diameter

• Prolonged inspiratory time

Page 38: Ventilatory support in special situations   balamugesh

Jet nebuliser system

• Mount nebuliser in inspiratory limb• Consider continuous nebulisation• Increase inspiratory time and decrease respiratory

rate• Use a spacer• Stop humidification• Delivery may be improved by inspiratory triggering

Page 39: Ventilatory support in special situations   balamugesh

Ventilator strategies in Bronchopleural fistula

Page 40: Ventilatory support in special situations   balamugesh

• Air escaping through the BPF• delays healing of the fistulous track• significant loss of tidal volume, jeopardizing

the minute ventilation and oxygenation

Page 41: Ventilatory support in special situations   balamugesh

Measures to reduce air-leak

• Limit the amount of PEEP • Limit the effective tidal volume,• Shorten inspiratory time, • Reduce respiratory rate.• Use of double-lumen intubation with

differential lung ventilation,

Page 42: Ventilatory support in special situations   balamugesh

Chest tube

• To add positive intrapleural pressure during the expiratory phase to maintain PEEP

• Occlusion during the inspiratory phase to decrease BPF flow

Page 43: Ventilatory support in special situations   balamugesh

High-frequency ventilation (HFV)

• Useful in patients with normal lung parenchyma and proximal BPF

• Limited value in patients with distal disease and parenchymal disease.